4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000075
Chief Executive Officer sold 15,730 shares at $26.83 ($421,979)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2026-04-13 | Sale 10b5-1 | −15,730 | $26.83 | $421,979 | 689,321 | D |
| Open-market sales · 15,730 sh · avg $26.83 · $421,979 | |||||||
Loading xslF345X06/wk-form4_1776303917.xml…